1. Home
  2. NVNO vs EVOK Comparison

NVNO vs EVOK Comparison

Compare NVNO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$0.31

Market Cap

16.7M

Sector

Health Care

ML Signal

HOLD

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$10.98

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVNO
EVOK
Founded
1987
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.7M
18.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NVNO
EVOK
Price
$0.31
$10.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
959.3K
30.4K
Earning Date
10-31-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,424,652.00
Revenue This Year
N/A
$58.96
Revenue Next Year
N/A
$57.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.40
52 Week Low
$0.30
$1.94
52 Week High
$5.62
$10.99

Technical Indicators

Market Signals
Indicator
NVNO
EVOK
Relative Strength Index (RSI) 30.27 84.91
Support Level $0.32 $10.66
Resistance Level $0.37 $10.99
Average True Range (ATR) 0.04 0.05
MACD 0.01 -0.19
Stochastic Oscillator 6.34 93.10

Price Performance

Historical Comparison
NVNO
EVOK

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: